MeSH Review:
Breast Diseases
Tanaka,
Furuya,
Yamasaki,
Hanai,
Kuriki,
Kamiakito,
Kobayashi,
Yoshida,
Koike,
Fukayama,
Tan-Chiu,
Wang,
Costantino,
Paik,
Butch,
Wickerham,
Fisher,
Wolmark,
Shekhar,
Nangia-Makker,
Wolman,
Tait,
Heppner,
Visscher,
Crisan,
Ruark,
Decker,
Drevon,
Dicarlo,
Berns,
Foekens,
Vossen,
Look,
Devilee,
Henzen-Logmans,
van Staveren,
van Putten,
Inganäs,
Meijer-van Gelder,
Cornelisse,
Claassen,
Portengen,
Bakker,
Klijn,
Rohan,
Hartwick,
Miller,
Kandel,
- A population-based case-control study of thyroid cancer. Ron, E., Kleinerman, R.A., Boice, J.D., LiVolsi, V.A., Flannery, J.T., Fraumeni, J.F. J. Natl. Cancer Inst. (1987)
- Biochemical characterization and crystalization of human Zn-alpha2-glycoprotein, a soluble class I major histocompatibility complex homolog. Sánchez, L.M., López-Otín, C., Bjorkman, P.J. Proc. Natl. Acad. Sci. U.S.A. (1997)
- HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer. Stark, A., Hulka, B.S., Joens, S., Novotny, D., Thor, A.D., Wold, L.E., Schell, M.J., Melton, L.J., Liu, E.T., Conway, K. J. Clin. Oncol. (2000)
- High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8. Tanaka, A., Furuya, A., Yamasaki, M., Hanai, N., Kuriki, K., Kamiakito, T., Kobayashi, Y., Yoshida, H., Koike, M., Fukayama, M. Cancer Res. (1998)
- Effects of tamoxifen on benign breast disease in women at high risk for breast cancer. Tan-Chiu, E., Wang, J., Costantino, J.P., Paik, S., Butch, C., Wickerham, D.L., Fisher, B., Wolmark, N. J. Natl. Cancer Inst. (2003)
- Immunohistochemical detection of c-erbB-2 and p53 in benign breast disease and breast cancer risk. Rohan, T.E., Hartwick, W., Miller, A.B., Kandel, R.A. J. Natl. Cancer Inst. (1998)
- Serum steroid binding proteins and the bioavailability of estradiol in relation to breast diseases. Langley, M.S., Hammond, G.L., Bardsley, A., Sellwood, R.A., Anderson, D.C. J. Natl. Cancer Inst. (1985)
- Use of circulating pregnancy-specific beta 1 glycoprotein as a marker in carcinoma of the breast in women. Rosen, S.W., Gail, M.H., Tormey, D.C. J. Natl. Cancer Inst. (1982)
- Human tissue polypeptide antigen in breast cancer. Nemoto, T., Constantine, R., Chu, T.M. J. Natl. Cancer Inst. (1979)
- Estrogen replacement therapy and benign breast disease. Trapido, E.J., Brinton, L.A., Schairer, C., Hoover, R. J. Natl. Cancer Inst. (1984)
- Oral contraceptives as related to cancer and benign lesions of the breast. Fasal, E., Paffenbarger, R.S. J. Natl. Cancer Inst. (1975)
- Breast fluid cholesterol and cholesterol beta-epoxide concentrations in women with benign breast disease. Wrensch, M.R., Petrakis, N.L., Gruenke, L.D., Miike, R., Ernster, V.L., King, E.B., Hauck, W.W., Craig, J.C., Goodson, W.H. Cancer Res. (1989)
- Gemcitabine in combination with doxorubicin in advanced breast cancer: final results of a phase II pharmacokinetic trial. Pérez-Manga, G., Lluch, A., Alba, E., Moreno-Nogueira, J.A., Palomero, M., García-Conde, J., Khayat, D., Rivelles, N. J. Clin. Oncol. (2000)
- 31P magnetic resonance spectroscopic profiles of neoplastic human breast tissues. Merchant, T.E., Gierke, L.W., Meneses, P., Glonek, T. Cancer Res. (1988)
- Biallelic expression of the IGF2 gene in human breast disease. McCann, A.H., Miller, N., O'Meara, A., Pedersen, I., Keogh, K., Gorey, T., Dervan, P.A. Hum. Mol. Genet. (1996)
- Transforming growth factor alpha- and c-myc-induced mammary carcinogenesis in transgenic mice. Rose-Hellekant, T.A., Sandgren, E.P. Oncogene (2000)
- Inadequate corpus luteal function in women with benign breast diseases. Sitruk-ware, L.R., Sterkers, N., Mowszowicz, I., Mauvais-Jarvis, P. J. Clin. Endocrinol. Metab. (1977)
- Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation. Kittiniyom, K., Mastronardi, M., Roemer, M., Wells, W.A., Greenberg, E.R., Titus-Ernstoff, L., Newsham, I.F. Genes Chromosomes Cancer (2004)
- Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues. Chui, X., Egami, H., Yamashita, J., Kurizaki, T., Ohmachi, H., Yamamoto, S., Ogawa, M. Br. J. Cancer (1996)
- Aromatase activity in breast adipose tissue from women with benign and malignant breast diseases. O'Neill, J.S., Miller, W.R. Br. J. Cancer (1987)
- Human relaxins in normal, benign and neoplastic breast tissue. Tashima, L.S., Mazoujian, G., Bryant-Greenwood, G.D. J. Mol. Endocrinol. (1994)
- Quantitative cytochemistry of glucose-6-phosphate dehydrogenase in benign and malignant breast tumours. Barron, E.T., Smyth, P.P., McDermott, E.W., Tobbia, I.N., Higgins, N.J. Eur. J. Cancer (1991)
- Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases. Bánkfalvi, A., Ludwig, A., De-Hesselle, B., Buerger, H., Buchwalow, I.B., Boecker, W. Mod. Pathol. (2004)
- Effect of halothane and nitrous oxide anaesthesia on natural killer lymphocytes from patients with benign and malignant breast disease. Griffith, C.D., Kamath, M.B. British journal of anaesthesia. (1986)
- Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Marsh, D.J., Coulon, V., Lunetta, K.L., Rocca-Serra, P., Dahia, P.L., Zheng, Z., Liaw, D., Caron, S., Duboué, B., Lin, A.Y., Richardson, A.L., Bonnetblanc, J.M., Bressieux, J.M., Cabarrot-Moreau, A., Chompret, A., Demange, L., Eeles, R.A., Yahanda, A.M., Fearon, E.R., Fricker, J.P., Gorlin, R.J., Hodgson, S.V., Huson, S., Lacombe, D., Eng, C. Hum. Mol. Genet. (1998)
- Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Berns, E.M., Foekens, J.A., Vossen, R., Look, M.P., Devilee, P., Henzen-Logmans, S.C., van Staveren, I.L., van Putten, W.L., Inganäs, M., Meijer-van Gelder, M.E., Cornelisse, C., Claassen, C.J., Portengen, H., Bakker, B., Klijn, J.G. Cancer Res. (2000)
- Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study. Wong, S.Y., Purdie, A.T., Han, P. Am. J. Pathol. (1992)
- Transforming growth factor alpha and mouse models of human breast cancer. Humphreys, R.C., Hennighausen, L. Oncogene (2000)
- Molecular mediators of tumor angiogenesis: enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer. Kranz, A., Mattfeldt, T., Waltenberger, J. Int. J. Cancer (1999)
- Monoclonal antibodies reactive with mucin glycoproteins found in sera from breast cancer patients. Linsley, P.S., Brown, J.P., Magnani, J.L., Horn, D. Cancer Res. (1988)
- Direct action of estrogen on sequence of progression of human preneoplastic breast disease. Shekhar, M.P., Nangia-Makker, P., Wolman, S.R., Tait, L., Heppner, G.H., Visscher, D.W. Am. J. Pathol. (1998)
- Methylxanthines and benign breast disease. Schairer, C., Brinton, L.A., Hoover, R.N. Am. J. Epidemiol. (1986)
- Serum oestradiol in women with and without breast disease. Bennett, I.C., McCaffrey, J.F., McCaffrey, E., Wyatt, B. Br. J. Cancer (1990)
- Detection of circulating epithelial cells after surgery for benign breast disease. Crisan, D., Ruark, D.S., Decker, D.A., Drevon, A.M., Dicarlo, R.G. Mol. Diagn. (2000)